Global Diabetic Foot Infection (DFI) API Manufacturers, Marketed & Phase III Drugs Landscape Report 2017-2018 - Research & Ma...
February 17 2017 - 11:42AM
Business Wire
Research and Markets has announced the addition of the "Diabetic
Foot Infection (DFI) - Global API Manufacturers, Marketed and Phase
III Drugs Landscape, 2017" drug pipelines to their offering.
Diabetic Foot Infection (DFI) - Global API Manufacturers,
Marketed and Phase III Drugs Landscape, 2017, provides
comprehensive insights about the marketed drugs, drug sales, Phase
III pipeline drugs and their API Manufacturers across the
globe.
A key objective of the Diabetic Foot Infection (DFI) Report is
to understand the market and pipeline status of the drugs around
the Diabetic Foot Infection (DFI) to explore the generic
development opportunities, licensing opportunities and to gain
competitive advantage on designing pipeline strategies. The Report
provides the historical and forecasted sales of the drugs till
2018.
The Diabetic Foot Infection (DFI) Report gives insights into
patents providing the patent protection data and marketing
exclusivity of all the drugs across the Diabetic Foot Infection
(DFI).
While the leading brands, companies and chemicals are considered
thoroughly, the report also provides details on the Global API
Manufacturers across the globe covering Drug Master Filings of US,
Europe and API Manufacturers in Asia specifically China and
India.
Key Topics Covered:
1. Indication Overview
2. Market Drugs Landscape
3. Global API Manufacturers Assessment
4. Phase III Drugs Landscape
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Diabetic Foot Infection (DFI)
7. Phase III Drugs for Diabetic Foot Infection (DFI)
8. Discontinued Drugs for Diabetic Foot Infection (DFI)
9. Appendix
For more information about this drug pipelines report visit
http://www.researchandmarkets.com/research/zln4jd/diabetic_foot
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170217005546/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Related Topics: Infectious Diseases Drugs,
Endocrine and Metabolic Disorders Drugs